Mesothelioma.com Resources for Patients and their Families
Request Free Guide

Mesothelioma Doctors

Pasi A. Janne, MD, PhD

Dr. Janne
Boston, MA

Dr. Pasi A. Janne

Director, Lowe Center for Thoracic Oncology

Dana-Farber Cancer Institute

450 Brookline Avenue, HIM 223
Boston, MA 02215
877.332.4294

Need Help Contacting This Doctor?

Dr. Pasi A. Janne is a thoracic medical oncologist at the Dana-Farber Cancer Institute. He also is a professor at Harvard Medical School and the director of the Lowe Center for Thoracic Oncology, as well as director of the Belfer Center for Applied Cancer Science. Dr. Janne's main research insterests include the therapeutic relevance of oncogenic alterations in lung cancer. He is affiliated with the cancer genetics and lung cancer programs at Dana-Farber/Harvard Cancer Center.

Dr. Janne has contributed to a number of peer-reviewed journals as an author and co-author. Some of those publications include The New England Journal of Medicine, Oncology, The Journal of the National Cancer Institute, Science, and Cancer Research.

Main Specialty: Thoracic Oncology

Other Interests & Specialties: Epidermal growth factor receptor targeted therapies, lung cancer, targeted therapies and translational medicine.

Certifications, Awards & Accolades: American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Certification in Medical Oncology, George P. Canellos Award for Excellence in Clinical Investigation and Patient Care, American Society of Clinical Oncology's Merit Award, Hope Now Award for Lung Cancer Research, Team Science Award, Richard and Hinda Rosenthal Memorial Award, Research Excellence Award

Education & Experience:

Publications:
Imaging of lung cancer in the era of molecular medicine. Academic Radiology. April 2011;18(4): 424-36. doi: 10.1016/j.acra.2010.10.020

Osimertinib in patients with T790M mutation-positive, advanced non-small cell lung cancer: Long-Term follow-up from a pooled analysis of 2 phase 2 studies. Cancer. December 2018. doi: 10.1002/cncr.31891

Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma. Cancer Research. September 2002; 62(18): 5242-7.

Mesothelioma Clinical Trials by Pasi A. Janne, MD, PhD

Dr. Janne is associated with the following clinical trials:

Author: Linda Molinari

Editor in Chief, Mesothelioma Cancer Alliance

Linda Molinari

Reviewer: Annette Charlevois

Patient Support Coordinator

Annette Charlevois
Share
Tweet
Share
Mesothelioma Treatment Guide

Free Mesothelioma Treatment Guide

Please fill in the form below to request our FREE Mesothelioma Treatment Guide. It will be sent to you within 24 hours.

Have you or someone you know been diagnosed with mesothelioma?

Get Access To:

Legal Rights Information Guide Free Guide Request Free Guide Free Mesothelioma Guide Free 2019 Mesothelioma Guide